Gene · 2071
Papers2,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 2,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epithelial-Mesenchymal Transition and MicroRNAs in Colorectal Cancer Chemoresistance to FOLFOX. | Pharmaceutics | 2021 | 33429840 | PubTator, text mining | PubMed |
| XPF expression and its relationship with the risk and prognosis of colorectal cancer. | Cancer Cell Int | 2021 | 33407486 | PubTator, text mining | PubMed |
| The UVSSA complex alleviates MYC-driven transcription stress. | J Cell Biol | 2021 | 33404608 | PubTator, text mining | PubMed |
| Predicting changes in renal metabolism after compound exposure with a genome-scale metabolic model. | Toxicol Appl Pharmacol | 2021 | 33387578 | PubTator, text mining | PubMed |
| Spironolactone-induced XPB degradation requires TFIIH integrity and ubiquitin-selective segregase VCP/p97. | Cell Cycle | 2021 | 33381997 | PubTator, text mining | PubMed |
| ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients. | J Exp Med | 2021 | 33315086 | PubTator, text mining | PubMed |
| Molecular basis of transcriptional pausing, stalling, and transcription-coupled repair initiation. | Biochim Biophys Acta Gene Regul Mech | 2021 | 33271312 | PubTator, text mining | PubMed |
| Does the proteasome inhibitor bortezomib sensitize to DNA-damaging therapy in gastroenteropancreatic neuroendocrine neoplasms? - A preclinical assessment in vitro and in vivo. | Neoplasia | 2021 | 33246310 | PubTator, text mining | PubMed |
| The XPB Subunit of the TFIIH Complex Plays a Critical Role in HIV-1 Transcription and XPB Inhibition by Spironolactone Prevents HIV-1 Reactivation from Latency. | J Virol | 2021 | 33239456 | PubTator, text mining | PubMed |
| Spatial profiling of gastric cancer patient-matched primary and locoregional metastases reveals principles of tumour dissemination. | Gut | 2021 | 33229445 | PubTator, text mining | PubMed |
| Structural and dynamical insights into the PH domain of p62 in human TFIIH. | Nucleic Acids Res | 2021 | 33211877 | PubTator, text mining | PubMed |
| Identification of a Synthetic Lethal Relationship between Nucleotide Excision Repair Deficiency and Irofulven Sensitivity in Urothelial Cancer. | Clin Cancer Res | 2021 | 33208343 | PubTator, text mining | PubMed |
| Targeting Germline- and Tumor-Associated Nucleotide Excision Repair Defects in Cancer. | Clin Cancer Res | 2021 | 33199492 | PubTator, text mining | PubMed |
| Thyroid nodules in xeroderma pigmentosum patients: a feature of premature aging. | J Endocrinol Invest | 2021 | 33155181 | PubTator, text mining | PubMed |
| enAsCas12a Enables CRISPR-Directed Evolution to Screen for Functional Drug Resistance Mutations in Sequences Inaccessible to SpCas9. | Mol Ther | 2021 | 33002419 | PubTator, text mining | PubMed |
| Exome and genome sequencing in adults with undiagnosed disease: a prospective cohort study. | J Med Genet | 2021 | 32581083 | PubTator, text mining | PubMed |
| Small-molecule drug repurposing to target DNA damage repair and response pathways. | Semin Cancer Biol | 2021 | 32113999 | PubTator, text mining | PubMed |
| Discovery of autism/intellectual disability somatic mutations in Alzheimer's brains: mutated ADNP cytoskeletal impairments and repair as a case study. | Mol Psychiatry | 2021 | 31664177 | PubTator, text mining | PubMed |
| Association of XRCC3 18067 C>T (Thr241Met) polymorphism with risk of cervical and ovarian cancers: A systematic review and meta-analysis. | Interv Med Appl Sci | 2020 | 36343295 | PubTator, text mining | PubMed |
| Comparison of whole exome sequencing in circulating tumor cells of primitive and metastatic nasopharyngeal carcinoma. | Transl Cancer Res | 2020 | 35117778 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2071/papers?page=34